Aksh Optifibre Board of Directors

Get the latest insights into the leadership at Aksh Optifibre. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Kailash Shantilal Choudhari Chairman & Non-Exe.Director
Mr. Satyendra Kumar Gupta Vice Chairman & Non Exe.Dire
Mr. Sanjay Katyal Independent Director
Ms. Anuja Bansal Independent Director
Mr. Sunil Puri Independent Director
Mr. Harvinder Singh Independent Director

Aksh Optifibre Share price

AKSHOPTFBR

7.74

0.50 (-6.07%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:45 IST
BUYSELL
Today's High

8.36

Today's Low

7.62

52 Week Low

7.12

52 Week High

15.00

The current prices are delayed, login to your account for live prices

Aksh Optifibre FAQs

The board at Aksh Optifibre consists of experienced professionals, including Dr. Kailash Shantilal Choudhari , Mr. Satyendra Kumar Gupta , and others, overseeing the company’s strategic and corporate governance.

Directors at Aksh Optifibre are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Kailash Shantilal Choudhari is the current chairman at Aksh Optifibre.

Executive directors at Aksh Optifibre are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Aksh Optifibre adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Aksh Optifibre, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.